New adjuvants in evolving vaccine strategies

By Buonaguro Franco M   Tornesello Maria Lina   Buonaguro Luigi  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 827-832

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-1 and Interleukin-1 Fragments as Vaccine Adjuvants

By Boraschi D.   Tagliabue A.  

Methods, Vol. 19, Iss. 1, 1999-09 ,pp. : 108-113

Academic Press

Access to resources Recommend Favorite

The role of adjuvants in the development of mucosal vaccines

By Vajdy Michael   Singh Manmohan  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 7, 2005-07 ,pp. : 953-965

Informa Healthcare

Access to resources Recommend Favorite

New tuberculosis vaccine development

By Nacy Carol A   Sacksteder Katherine A  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 7, 2002-10 ,pp. : 741-749

Informa Healthcare

Access to resources Recommend Favorite

Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents

By Baldridge Jory R   McGowan Patrick   Evans Jay T   Cluff Christopher   Mossman Sally   Johnson David   Persing David  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 7, 2004-07 ,pp. : 1129-1138

Informa Healthcare

Access to resources Recommend Favorite